Skip to Main Content

The (POGO) Blog

November 30, 2015

By David S. Hilzenrath

Drug Problems: European Regulator Investigating Trial Led by FDA Nominee



1950 Photograph of a Physican and patient. European regulator EMA is investigating a clinical trial of the blood thinner Xarelto, which Robert Califf, President Obama’s nominee for FDA commissioner, helped lead.

Continue Reading Drug Problems: European Regulator Investigating Trial Led by FDA Nominee

Topics: Public Health and Science

October 20, 2015

By David S. Hilzenrath

FDA Approves Antidote for Pradaxa, Calls It “Necessary”



Blood Sample Scientist Lab Five years after approving the blood thinner Pradaxa without an antidote, the FDA approved an antidote and said it was “medically necessary” when bleeding “can’t be controlled."

Continue Reading FDA Approves Antidote for Pradaxa, Calls It “Necessary”

Topics: Public Health and Science

August 7, 2014

By POGO Guest Blogger

Los Alamos Firing Demonstrates Exactly What’s Wrong with Scientific Integrity at the Department of Energy



Los Alamos Lab My colleague Lisbeth Gronlund recently wrote about the unjust firing of James Doyle, a 17-year employee of Los Alamos National Laboratory. The Department of Energy could have avoided this public embarrassment if it had enacted a strong scientific integrity

Continue Reading Los Alamos Firing Demonstrates Exactly What’s Wrong with Scientific Integrity at the Department of Energy

Topics: Government Accountability

March 13, 2013

By David S. Hilzenrath

VA Suppressed Data on Gulf War Vets' Health Problems, Former Official Says



Stethescope The Department of Veterans Affairs has suppressed evidence that Gulf War veterans’ health problems could be linked to their exposure to toxic substances during the 1991 war, a former VA epidemiologist alleges.

Continue Reading VA Suppressed Data on Gulf War Vets' Health Problems, Former Official Says

Topics: Public Health and Science

February 12, 2013

By Andre Francisco

POGO's Staff Scientist Says New Doctor Rules Promote Transparency



Drug and FDA Issues New disclosure rules for doctors on advisory panels for the Food and Drug Administration are meant to increase transparency without discouraging doctors from serving on the panels, according to Ned Feder, POGO's staff scientist.

Continue Reading POGO's Staff Scientist Says New Doctor Rules Promote Transparency

Topics: Public Health and Science

Browse POGOBlog by Topic

POGO on Facebook

Latest Podcast

Podcast; Social Media, Internet Provides Opportunities, Challenges for Lawmakers

The Congressional Management Foundation offers the Gold Mouse Awards annually to members of Congress who make the most of the opportunity the digital world offers them. POGO spoke with members of Rep. Mike Honda's communications team about their award.